Table 5. Clinical characteristics of... | American Society of Hematology

Table 5.

Clinical characteristics of bcl-2 positive versus germline cases of FL in published series

Country	No. FL patients (positive forbcl-2)	Method of analysis	Clinical characteristics, bcl-2 positive versus germline cases
Country	No. FL patients (positive forbcl-2)	Method of analysis	Age	Sex	Stage	Histology	LDH	β₂M	BM	Enodal
United States¹¹³	30 (23)	CG	NS	NS	NS	NS	NS	—	—	—
United States⁹⁹	20 (13)	CG	NS	NS	NS	—	—	—	—	NS
Denmark⁹³	70 (39)	PCR	NS	NS	NS	NS	—	—	NS	—
Sweden⁸⁹	102 (42)	PCR	Younger^5-150	—	NS	—	NS	—	NS	NS
United States⁸³	247 (202)	PCR	Younger^5-152	—	Earlier^5-151	NS	Lower^5-152	Lower^5-151	—	NS
Canada⁹⁷	212 (164)	CG	NS	NS	Higher^5-150	Lower Gr^5-150	NS	—	Increase^5-150	Lower^5-151
United States⁹⁶	46 (22)	PCR	Younger^5-151	—	Earlier^5-151	—	—	—	Decrease^5-151	—

Country	No. FL patients (positive forbcl-2)	Method of analysis	Clinical characteristics, bcl-2 positive versus germline cases
Country	No. FL patients (positive forbcl-2)	Method of analysis	Age	Sex	Stage	Histology	LDH	β₂M	BM	Enodal
United States¹¹³	30 (23)	CG	NS	NS	NS	NS	NS	—	—	—
United States⁹⁹	20 (13)	CG	NS	NS	NS	—	—	—	—	NS
Denmark⁹³	70 (39)	PCR	NS	NS	NS	NS	—	—	NS	—
Sweden⁸⁹	102 (42)	PCR	Younger^5-150	—	NS	—	NS	—	NS	NS
United States⁸³	247 (202)	PCR	Younger^5-152	—	Earlier^5-151	NS	Lower^5-152	Lower^5-151	—	NS
Canada⁹⁷	212 (164)	CG	NS	NS	Higher^5-150	Lower Gr^5-150	NS	—	Increase^5-150	Lower^5-151
United States⁹⁶	46 (22)	PCR	Younger^5-151	—	Earlier^5-151	—	—	—	Decrease^5-151	—

β₂M indicates beta₂ microglobulin; BM, bone marrow; Enodal, extranodal; CG, cytogenetics; NS, not significant.

P < .01.

P = .01-.05.

P > .05.